glp 1 agonist long term side effects of glp-1 drugs TrimRX Did you know that GLP-1
Description
& de Hollanda, A
2027 to 2028 Commercial launch
European journal of preventive cardiology
A 2022 warning letter from the Office of Prescription Drug Promotion (OPDP) highlighted an Instagram ad posted by the company that reportedly made, false or misleading claims and representations about the benefits and risks of Trulicity. It found that the company minimized the risks and overemphasized the benefits of the drug
Kenney, Julia and Frida Velcani
